• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceStraumann Emdogain
Generic NameBiologic material, dental
Regulation Number872.3930
ApplicantThe Straumann Company
60 Minuteman Rd.
Andover, MA 01810
PMA NumberP930021
Supplement NumberS018
Date Received12/15/2017
Decision Date09/28/2018
Product Code NQA 
Advisory Committee Dental
Supplement Type135 Review Track For 30-Day Notice
Supplement Reason Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review Granted? No
Combination ProductYes
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval for: 1) Revision of ventilation and implementation of cooling in clean rooms;2) Emdogain bulk tank will be covered by a sterile autoclave bag during storage time between compounding and filling;3) Implementation of heat-sealed autoclave pouch for sterilization and storage of stopper hopper;4) The sterile phase of the P2R2 autoclave program, validated for sterilization of filters and other equipment used for aseptic production, was increased from 20 to 25 min;5) Sampling and weighing method of the PGA has been changed to be conducted in plastic Nalgene bottles; 6) The rules for analysis and reference sampling for each sub batch of Emdogain were updated to reduce the overall number of samples taken per day;7) Specifications for nitrogen gas and compressed air were updated; and8) An alternative IPC method (IR spectroscopy) for protein content determination in Emdogain process intermediates has been validated and implemented.
-
-